(DSGX) Descartes Systems - Ratings and Ratios
Exchange: NASDAQ •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA2499061083
Routing, Compliance, Visibility, Telematics, Connectivity
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 31.6% |
| Value at Risk 5%th | 49.1% |
| Relative Tail Risk | -5.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.77 |
| Alpha | -37.88 |
| CAGR/Max DD | 0.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.609 |
| Beta | 0.922 |
| Beta Downside | 0.763 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.29% |
| Mean DD | 7.80% |
| Median DD | 5.14% |
Description: DSGX Descartes Systems November 04, 2025
Descartes Systems Group Inc. (NASDAQ:DSGX) delivers a cloud-based logistics technology platform that enables customers to route, schedule, track, and bill transportation assets, manage customs compliance, and access global trade intelligence. Its modular SaaS suite spans routing & telematics, transportation management, e-commerce fulfillment, broker/forwarder ERP, and B2B connectivity, serving carriers, third-party logistics providers, freight forwarders, customs brokers, and distribution-intensive manufacturers and retailers.
Key recent metrics indicate the business is scaling: FY 2023 revenue reached approximately $1.2 billion, up ~7 % YoY, with subscription-based ARR now exceeding $800 million and an operating margin of roughly 18 %. Growth is being driven by macro trends such as accelerating e-commerce volumes, increasing regulatory complexity in cross-border trade, and a broader industry shift toward digitizing supply-chain operations, which together boost demand for integrated, data-rich logistics solutions.
If you want a data-rich, scenario-based valuation to gauge DSGX’s upside potential, ValueRay’s analytical tools and model library provide a useful next step for deeper research.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (155.1m TTM) > 0 and > 6% of Revenue (6% = 42.1m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA 0.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 25.98% (prev 11.86%; Δ 14.13pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 250.3m > Net Income 155.1m (YES >=105%, WARN >=100%) |
| Net Debt (-271.1m) to EBITDA (287.5m) ratio: -0.94 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.83 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (87.6m) change vs 12m ago 0.31% (target <= -2.0% for YES) |
| Gross Margin 73.88% (prev 70.67%; Δ 3.21pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.81% (prev 38.93%; Δ 1.88pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 208.9 (EBITDA TTM 287.5m / Interest Expense TTM 964.6k) >= 6 (WARN >= 3) |
Altman Z'' 6.40
| (A) 0.10 = (Total Current Assets 400.9m - Total Current Liabilities 218.6m) / Total Assets 1.82b |
| (B) 0.26 = Retained Earnings (Balance) 482.0m / Total Assets 1.82b |
| (C) 0.12 = EBIT TTM 201.5m / Avg Total Assets 1.72b |
| (D) 3.89 = Book Value of Equity 1.05b / Total Liabilities 269.0m |
| Total Rating: 6.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.83
| 1. Piotroski 7.0pt |
| 2. FCF Yield 3.18% |
| 3. FCF Margin 34.76% |
| 4. Debt/Equity 0.00 |
| 5. Debt/Ebitda -0.94 |
| 6. ROIC - WACC (= 0.90)% |
| 7. RoE 10.54% |
| 8. Rev. Trend 98.84% |
| 9. EPS Trend 66.45% |
What is the price of DSGX shares?
As of December 14, 2025, the stock is trading at USD 90.71 with a total of 396,034 shares traded.
Over the past week, the price has changed by -2.20%, over one month by +7.58%, over three months by -13.03% and over the past year by -25.18%.
Over the past week, the price has changed by -2.20%, over one month by +7.58%, over three months by -13.03% and over the past year by -25.18%.
Is DSGX a buy, sell or hold?
Descartes Systems has received a consensus analysts rating of 3.93.
Therefore, it is recommended to buy DSGX.
- Strong Buy: 5
- Buy: 4
- Hold: 4
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the DSGX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 111.5 | 23% |
| Analysts Target Price | 111.5 | 23% |
| ValueRay Target Price | 86.3 | -4.9% |
DSGX Fundamental Data Overview December 13, 2025
Market Cap USD = 7.93b (7.93b USD * 1.0 USD.USD)
P/E Trailing = 52.7086
P/E Forward = 30.3951
P/S = 11.2709
P/B = 5.1115
P/EG = 2.6627
Beta = 0.356
Revenue TTM = 701.8m USD
EBIT TTM = 201.5m USD
EBITDA TTM = 287.5m USD
Long Term Debt = 7.60m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.48m USD (from shortTermDebt, last quarter)
Debt = 7.60m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -271.1m USD (from netDebt column, last quarter)
Enterprise Value = 7.66b USD (7.93b + Debt 7.60m - CCE 278.7m)
Interest Coverage Ratio = 208.9 (Ebit TTM 201.5m / Interest Expense TTM 964.6k)
FCF Yield = 3.18% (FCF TTM 244.0m / Enterprise Value 7.66b)
FCF Margin = 34.76% (FCF TTM 244.0m / Revenue TTM 701.8m)
Net Margin = 22.10% (Net Income TTM 155.1m / Revenue TTM 701.8m)
Gross Margin = 73.88% ((Revenue TTM 701.8m - Cost of Revenue TTM 183.3m) / Revenue TTM)
Gross Margin QoQ = 66.34% (prev 76.87%)
Tobins Q-Ratio = 4.21 (Enterprise Value 7.66b / Total Assets 1.82b)
Interest Expense / Debt = 3.18% (Interest Expense 241.6k / Debt 7.60m)
Taxrate = 24.75% (14.3m / 57.8m)
NOPAT = 151.6m (EBIT 201.5m * (1 - 24.75%))
Current Ratio = 1.83 (Total Current Assets 400.9m / Total Current Liabilities 218.6m)
Debt / Equity = 0.00 (Debt 7.60m / totalStockholderEquity, last quarter 1.55b)
Debt / EBITDA = -0.94 (Net Debt -271.1m / EBITDA 287.5m)
Debt / FCF = -1.11 (Net Debt -271.1m / FCF TTM 244.0m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.52% (Net Income 155.1m / Total Assets 1.82b)
RoE = 10.54% (Net Income TTM 155.1m / Total Stockholder Equity 1.47b)
RoCE = 13.62% (EBIT 201.5m / Capital Employed (Equity 1.47b + L.T.Debt 7.60m))
RoIC = 10.30% (NOPAT 151.6m / Invested Capital 1.47b)
WACC = 9.40% (E(7.93b)/V(7.94b) * Re(9.41%) + D(7.60m)/V(7.94b) * Rd(3.18%) * (1-Tc(0.25)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.47%
[DCF Debug] Terminal Value 74.71% ; FCFE base≈227.7m ; Y1≈246.0m ; Y5≈304.5m
Fair Price DCF = 48.58 (DCF Value 4.18b / Shares Outstanding 86.0m; 5y FCF grow 9.05% → 3.0% )
EPS Correlation: 66.45 | EPS CAGR: 0.53% | SUE: -1.55 | # QB: 0
Revenue Correlation: 98.84 | Revenue CAGR: 14.35% | SUE: 0.39 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.60 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=2
EPS next Year (2027-01-31): EPS=2.66 | Chg30d=-0.003 | Revisions Net=+1 | Growth EPS=+11.9% | Growth Revenue=+10.8%
P/E Trailing = 52.7086
P/E Forward = 30.3951
P/S = 11.2709
P/B = 5.1115
P/EG = 2.6627
Beta = 0.356
Revenue TTM = 701.8m USD
EBIT TTM = 201.5m USD
EBITDA TTM = 287.5m USD
Long Term Debt = 7.60m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.48m USD (from shortTermDebt, last quarter)
Debt = 7.60m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -271.1m USD (from netDebt column, last quarter)
Enterprise Value = 7.66b USD (7.93b + Debt 7.60m - CCE 278.7m)
Interest Coverage Ratio = 208.9 (Ebit TTM 201.5m / Interest Expense TTM 964.6k)
FCF Yield = 3.18% (FCF TTM 244.0m / Enterprise Value 7.66b)
FCF Margin = 34.76% (FCF TTM 244.0m / Revenue TTM 701.8m)
Net Margin = 22.10% (Net Income TTM 155.1m / Revenue TTM 701.8m)
Gross Margin = 73.88% ((Revenue TTM 701.8m - Cost of Revenue TTM 183.3m) / Revenue TTM)
Gross Margin QoQ = 66.34% (prev 76.87%)
Tobins Q-Ratio = 4.21 (Enterprise Value 7.66b / Total Assets 1.82b)
Interest Expense / Debt = 3.18% (Interest Expense 241.6k / Debt 7.60m)
Taxrate = 24.75% (14.3m / 57.8m)
NOPAT = 151.6m (EBIT 201.5m * (1 - 24.75%))
Current Ratio = 1.83 (Total Current Assets 400.9m / Total Current Liabilities 218.6m)
Debt / Equity = 0.00 (Debt 7.60m / totalStockholderEquity, last quarter 1.55b)
Debt / EBITDA = -0.94 (Net Debt -271.1m / EBITDA 287.5m)
Debt / FCF = -1.11 (Net Debt -271.1m / FCF TTM 244.0m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.52% (Net Income 155.1m / Total Assets 1.82b)
RoE = 10.54% (Net Income TTM 155.1m / Total Stockholder Equity 1.47b)
RoCE = 13.62% (EBIT 201.5m / Capital Employed (Equity 1.47b + L.T.Debt 7.60m))
RoIC = 10.30% (NOPAT 151.6m / Invested Capital 1.47b)
WACC = 9.40% (E(7.93b)/V(7.94b) * Re(9.41%) + D(7.60m)/V(7.94b) * Rd(3.18%) * (1-Tc(0.25)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.47%
[DCF Debug] Terminal Value 74.71% ; FCFE base≈227.7m ; Y1≈246.0m ; Y5≈304.5m
Fair Price DCF = 48.58 (DCF Value 4.18b / Shares Outstanding 86.0m; 5y FCF grow 9.05% → 3.0% )
EPS Correlation: 66.45 | EPS CAGR: 0.53% | SUE: -1.55 | # QB: 0
Revenue Correlation: 98.84 | Revenue CAGR: 14.35% | SUE: 0.39 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.60 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=2
EPS next Year (2027-01-31): EPS=2.66 | Chg30d=-0.003 | Revisions Net=+1 | Growth EPS=+11.9% | Growth Revenue=+10.8%
Additional Sources for DSGX Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle